Chika V Anekwe, Antonio Cano, Jennifer Mulligan, Seng Bin Ang, Corinne N Johnson, Nick Panay, Zoe Schaedel, Eftitan Y Akam, Florence Porterfield, Emily Wang, Rossella E Nappi
{"title":"The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions.","authors":"Chika V Anekwe, Antonio Cano, Jennifer Mulligan, Seng Bin Ang, Corinne N Johnson, Nick Panay, Zoe Schaedel, Eftitan Y Akam, Florence Porterfield, Emily Wang, Rossella E Nappi","doi":"10.1080/13697137.2025.2548806","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Menopause, typically occurring between ages 45 and 55 years, is a natural life stage marked by hormonal changes that can affect the symptom burden, quality of life and chronic disease risk. While not a disease, the transition often requires individualized, holistic care. Lifestyle medicine - encompassing healthy eating, physical activity, mental well-being, avoidance of risky substances, restorative sleep and healthy relationships - offers a promising non-pharmacological strategy to optimize health during this period.</p><p><strong>Method: </strong>A systematic literature search was conducted in PubMed, Embase, Scopus and Web of Science (January 2000-December 2024) using the following keywords and combinations: 'menopause', 'lifestyle medicine', 'healthy eating', 'physical activity', 'mental wellbeing', 'avoidance of risky substances', 'restorative sleep', 'healthy relationships', 'weight management', 'chronic disease prevention', 'health equity and access' and 'general health frameworks'. Peer-reviewed human studies in perimenopausal, menopausal or postmenopausal women evaluating one or more lifestyle medicine pillars were included. Data were extracted on study design, population, interventions, outcomes and main findings.</p><p><strong>Results: </strong>Lifestyle medicine interventions were associated with reductions in vasomotor symptoms, improved sleep quality, enhanced mental well-being, healthier weight regulation, and reduced cardiometabolic and osteoporosis risk. Multidisciplinary, person-centered approaches improved adherence and patient-reported outcomes. Strategies were cost-effective, adaptable and beneficial for long-term disease prevention across diverse populations.</p><p><strong>Conclusion: </strong>Lifestyle medicine offers a foundational, evidence-based framework for equitable menopause care. Integrating these strategies into clinical guidelines and public health policy can improve quality of care, empower women to manage their health and reduce disparities in access. Collaborative action among healthcare providers, policymakers and communities is essential to maximize impact.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":" ","pages":"1-19"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2025.2548806","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Menopause, typically occurring between ages 45 and 55 years, is a natural life stage marked by hormonal changes that can affect the symptom burden, quality of life and chronic disease risk. While not a disease, the transition often requires individualized, holistic care. Lifestyle medicine - encompassing healthy eating, physical activity, mental well-being, avoidance of risky substances, restorative sleep and healthy relationships - offers a promising non-pharmacological strategy to optimize health during this period.
Method: A systematic literature search was conducted in PubMed, Embase, Scopus and Web of Science (January 2000-December 2024) using the following keywords and combinations: 'menopause', 'lifestyle medicine', 'healthy eating', 'physical activity', 'mental wellbeing', 'avoidance of risky substances', 'restorative sleep', 'healthy relationships', 'weight management', 'chronic disease prevention', 'health equity and access' and 'general health frameworks'. Peer-reviewed human studies in perimenopausal, menopausal or postmenopausal women evaluating one or more lifestyle medicine pillars were included. Data were extracted on study design, population, interventions, outcomes and main findings.
Results: Lifestyle medicine interventions were associated with reductions in vasomotor symptoms, improved sleep quality, enhanced mental well-being, healthier weight regulation, and reduced cardiometabolic and osteoporosis risk. Multidisciplinary, person-centered approaches improved adherence and patient-reported outcomes. Strategies were cost-effective, adaptable and beneficial for long-term disease prevention across diverse populations.
Conclusion: Lifestyle medicine offers a foundational, evidence-based framework for equitable menopause care. Integrating these strategies into clinical guidelines and public health policy can improve quality of care, empower women to manage their health and reduce disparities in access. Collaborative action among healthcare providers, policymakers and communities is essential to maximize impact.
目的:绝经期通常发生在45岁至55岁之间,是一个自然的生命阶段,其特征是激素变化,可影响症状负担、生活质量和慢性疾病风险。虽然不是一种疾病,但这种转变往往需要个性化的整体护理。生活方式医学——包括健康饮食、身体活动、精神健康、避免危险物质、恢复性睡眠和健康的人际关系——为优化这一时期的健康提供了一种有希望的非药物策略。方法:系统检索PubMed、Embase、Scopus和Web of Science(2000年1月- 2024年12月)的相关文献,检索关键词及组合为:“更年期”、“生活方式医学”、“健康饮食”、“身体活动”、“心理健康”、“避免危险物质”、“恢复性睡眠”、“健康关系”、“体重管理”、“慢性疾病预防”、“健康公平与获取”和“一般健康框架”。在围绝经期、绝经期或绝经后妇女中评估一种或多种生活方式药物支柱的同行评审人类研究被纳入。提取研究设计、人群、干预措施、结果和主要发现的数据。结果:生活方式药物干预与减少血管舒缩症状、改善睡眠质量、增强心理健康、更健康的体重调节、降低心血管代谢和骨质疏松症风险相关。多学科、以人为中心的方法改善了依从性和患者报告的结果。战略具有成本效益,适应性强,有利于在不同人群中长期预防疾病。结论:生活方式医学为公平的更年期护理提供了基础的、循证的框架。将这些战略纳入临床指导方针和公共卫生政策,可以提高护理质量,增强妇女管理自身健康的能力,并减少在获得服务方面的差距。医疗保健提供者、政策制定者和社区之间的合作行动对于最大限度地发挥影响至关重要。
期刊介绍:
Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.
Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.
The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.